Skip to content
← Lobby register
TP
Other

Takeda Pharmaceuticals International AG

🇪🇺 SWITZERLANDRegistered 17/05 staff
Disclosed budget
€1,000,000 — €1,249,999
Meetings 12mo
9
Policy files
0
Accredited passes
3

Recent meetings

DateCommissioner / CabinetTopicFile
28 Apr 2026
Jana Dabbelt
Cabinet member
EUCOPE - StrasbourgSRC
28 Apr 2026
Jana Dabbelt
Cabinet member
EUCOPE - Strasbourg
03 Dec 2025
Ulla Schwager
Head of Unit
Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sectorSRC
03 Dec 2025
Ulla Schwager
Head of Unit
Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sector
02 Oct 2025
Olivér Várhelyi
Commissioner
All pressing portfolio topicsSRC
02 Oct 2025
Jana Dabbelt
Cabinet member
All pressing portfolio topicsSRC
02 Oct 2025
Jana Dabbelt
Cabinet member
All pressing portfolio topics
25 Jun 2025
Patricia Reilly
Cabinet member
the EU biopharmaceutical landscapeSRC
25 Jun 2025
Patricia Reilly
Cabinet member
the EU biopharmaceutical landscape
20 Jan 2023
Elina Melngaile
Cabinet member
EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing PracticesSRC
20 Jan 2023
Elina Melngaile
Cabinet member
EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices
14 Sept 2017
Manuel Mateo-Goyet
Cabinet member
eHealthSRC
14 Sept 2017
Manuel Mateo-Goyet
Cabinet member
eHealth

Mission & Goals

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 244-year history in Japan. Established by our founding spirit and integral to every part of our business, Takeda-ism and our priorities (Patient, Trust, Reputation, Business) guide us in our efforts to achieve our Vision 2025. Takeda is headquartered in Tokyo, Japan and focuses its R&D on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. We aspire to bring our leadership in translating science into life-changing medicines to the next level, in our core focus areas: oncology, gastroentero (...)

EU Legislative Interests

We follow EU initiatives, policies and legislative files related to our Pharmaceuticals and Vaccines businesses. This includes topics such as R&D and clinical trials, data protection, relevant pharmaceutical legislation and initiatives, medical devices, trade & IP, environment.

Communication Activities

Mainly via participation at events organised by Trade Associations.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Takeda is a member of European Federation of Pharmaceutical Industries and Associations (EFPIA) and Vaccines Europe. Takeda is member of EUCOPE (European Confederation of Pharmaceutical Enterpreneurs). Takeda is also member of PPTA Europe, Japanese Business Council Europe and MedTech Europe.

Organisation Members

For more details see www.takeda.com

Additional Information

Declaration as per guidelines from the EU Transparency Register. Source for EU funding as per Financial Transparency Register